足跟垫治疗中段跟腱病的疗效(LIFT试验):一项随机对照试验的研究方案
LIFT试验计划招募108名18至65岁中段跟腱病患者,随机分为足跟垫组与假足跟垫组,每日使用至少8小时、持续12周,主要结局为过去一周最严重疼痛强度(数字评定量表),并嵌入40人亚组的生物力学分析。
要点
- 足跟垫治疗中段跟腱病的疗效与作用机制尚不明确,本试验为首项对比假干预的随机对照试验。
- 两组均接受关于可接受疼痛水平的教育,确保所有参与者获得某种形式的治疗。
- 主要结局为第12周时过去一周最严重疼痛强度(数字评定量表),采用意向性分析。
核心结论
- LIFT试验将是首个比较足跟垫与假干预减轻跟腱病患者疼痛和功能障碍疗效的随机试验,其生物力学分析将为了解足跟垫的作用机制提供有用见解。
研究设计与样本
- 随机对照试验,计划招募108名18至65岁中段跟腱病男女患者,使用Sealed Envelope网站随机分为对照组(假足跟垫)或试验组(足跟垫)。
- 参与者被指导每天至少使用分配干预8小时,持续12周;数据在基线及主要终点(第12周)收集,采用意向性分析。
- 在基线时对40名参与者亚组通过三维运动分析评估干预在步行和跑步时的急性动力学和运动学效应。
主要发现
- 原文未报告结果。
关键数值与推荐
- 主要结局指标为过去一周最严重疼痛强度(数字评定量表)。
- 次要结局指标包括跟腱疼痛和功能障碍的其他测量、参与者感知的整体变化评级、功能、身体活动水平和健康相关生活质量。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Mid-portion Achilles tendinopathy is a common condition, characterised by localised Achilles tendon load-related pain and dysfunction. Numerous non-surgical treatments have been proposed for the treatment of this condition, but many of these treatments have a poor or non-existent evidence base. Heel lifts have also been advocated as a treatment for Achilles tendinopathy, but the efficacy and mechanism of action of this intervention is unclear. This proposal describes a randomised controlled trial comparing the effectiveness of heel lifts versus sham heel lifts for reducing pain associated with mid-portion Achilles tendinopathy, with an embedded biomechanical analysis. METHODS: One hundred and eight men and women aged 18 to 65 years with mid-portion Achilles tendinopathy (who satisfy the inclusion and exclusion criteria) will be recruited. Participants will be randomised, using the website Sealed Envelope, to either a control group (sham heel lifts) or an experimental group (heel lifts). Both groups will be provided with education regarding acceptable pain levels to ensure all participants receive some form of treatment. The participants will be instructed to use their allocated intervention for at least 8 h every day for 12 weeks. The primary outcome measure will be pain intensity (numerical rating scale) at its worst over the previous week. The secondary outcome measures will be additional measures of Achilles tendon pain and disability, participant-perceived global ratings of change, function, level of physical activity and health-related quality of life. Data will be collected at baseline and the primary endpoint (week 12). Data will be analysed using the intention-to-treat principle. In addition, the acute kinetic and kinematic effects of the interventions will be examined at baseline in a subpopulation of the participants (n = 40) while walking and running using three-dimensional motion analysis. DISCUSSION: The LIFT trial (efficacy of heeL lIfts For mid-portion Achilles Tendinopathy) will be the first randomised trial to compare the efficacy of heel lifts to a sham intervention in reducing pain and disability in people with Achilles tendinopathy. The biomechanical analysis will provide useful insights into the mechanism of action of heel lifts. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry, ACTRN12623000627651 . Registered 7 June 2023.
引用
- Bourke J, Munteanu S, Garofolini A, et al. Efficacy of heel lifts for mid-portion Achilles tendinopathy (the LIFT trial): study protocol for a randomised controlled trial. Trials. 2024. PMID: 38790025. doi:10.1186/s13063-024-08185-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。